Skip to main content
Billions Co.,Ltd. logo

Billions Co.,Ltd. — Investor Relations & Filings

Ticker · 044480 ISIN · KR7044480002 KO Wholesale and retail trade
Open in API
Filings indexed 590 across all filing types
Latest filing 2021-02-09 Major Shareholding Noti…
Country KR South Korea
Listing KO 044480

About Billions Co.,Ltd.

http://www.unidus.co.kr

Billions Co.,Ltd. is a company with diversified operations in the entertainment and manufacturing sectors. In the entertainment field, the company is involved in artist management and the production of dramas and movies. Concurrently, its manufacturing division produces and markets latex medical products, including prophylactics, surgical gloves, and finger cots. The company has previously operated under different names, including Blade Entertainment Co Ltd and Unidus Corporation, reflecting its distinct business segments.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity's shareholding in a listed company crosses certain thresholds (typically 5%). This document details the shareholding changes, including acquisitions and disposals, by 'SJ Equity Co., Ltd.' in 'Kyungnam Bio Pharma'. Since this is a specific regulatory disclosure regarding major shareholding notifications, it falls under the 'Major Shareholding Notification' category.
2021-02-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the '5% Rule' report). It details the acquisition, disposal, and changes in shareholding percentages by a specific entity (SJEQUITY CO. LTD) in a listed company (Kyungnam Bio Pharma). This type of filing is used to notify the market of significant ownership changes and does not fit into categories like Annual Reports, Earnings Releases, or Board Announcements. As it is a specific regulatory disclosure regarding share ownership thresholds, it falls under the 'Major Shareholding Notification' category.
2021-01-21 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of convertible bonds and subsequent conversion into shares by Sachem Value Asia Partners in Kyungnam Bio Pharma. This type of filing is a mandatory disclosure of significant share ownership changes, which falls under the 'Major Shareholding Notification' category.
2020-12-17 Korean
전환청구권행사(제3회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Kyungnam Bio Pharma) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This type of filing details the conversion of debt into equity, which directly impacts the company's capital structure and share count. Under the provided definitions, this falls under 'Share Issue/Capital Change' (SHA) as it relates to the issuance of new shares resulting from the conversion of convertible bonds.
2020-12-17 Korean
기타경영사항(자율공시)(제3회차 무기명식 이권부 무보증 사모 전환사채 취득 후 재매각의 건)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the resale of convertible bonds (a financial instrument) by Gyeongnam Bio Pharma. It details the transaction amount, purpose (liquidity), and impact on capital. This falls under 'Capital/Financing Update' as it relates to the company's capital structure and financing activities.
2020-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register (stock transfer suspension) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2020-12-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.